ALDOC Human (+/-)-Aegeline multiple interactions ISO Aldoc (Mus musculus) 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of ALDOA mRNA CTD PMID:28843594 ALDOC Human (-)-alpha-phellandrene increases expression EXP 6480464 alpha phellandrene results in increased expression of ALDOC mRNA CTD PMID:25075043 ALDOC Human (-)-epigallocatechin 3-gallate increases expression EXP 6480464 epigallocatechin gallate results in increased expression of ALDOC protein CTD PMID:31195006 ALDOC Human (1->4)-beta-D-glucan multiple interactions ISO Aldoc (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ALDOA mRNA CTD PMID:36331819 ALDOC Human (RS)-coclaurine multiple interactions ISO Aldoc (Mus musculus) 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of ALDOA mRNA CTD PMID:28843594 ALDOC Human (RS)-norcoclaurine multiple interactions ISO Aldoc (Mus musculus) 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of ALDOA mRNA CTD PMID:28843594 ALDOC Human (S)-coclaurine multiple interactions ISO Aldoc (Mus musculus) 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of ALDOA mRNA CTD PMID:28843594 ALDOC Human 1,10-phenanthroline increases expression EXP 6480464 1 and 10-phenanthroline results in increased expression of ALDOC mRNA CTD PMID:19502547 ALDOC Human 1,2-dimethylhydrazine decreases expression ISO Aldoc (Mus musculus) 6480464 1 more ... CTD PMID:22206623 ALDOC Human 17alpha-ethynylestradiol decreases expression ISO Aldoc (Rattus norvegicus) 6480464 Ethinyl Estradiol results in decreased expression of ALDOC mRNA CTD PMID:12655037 ALDOC Human 17alpha-ethynylestradiol multiple interactions ISO Aldoc (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ALDOA mRNA and [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ALDOC mRNA CTD PMID:17942748 ALDOC Human 17alpha-ethynylestradiol increases expression ISO Aldoc (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of ALDOA mRNA and Ethinyl Estradiol results in increased expression of ALDOC mRNA CTD PMID:17942748 and PMID:19400957 ALDOC Human 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of ALDOC mRNA CTD PMID:20106945 ALDOC Human 17beta-estradiol decreases expression ISO Aldoc (Mus musculus) 6480464 Estradiol results in decreased expression of ALDOA mRNA CTD PMID:19484750 ALDOC Human 17beta-estradiol increases expression ISO Aldoc (Mus musculus) 6480464 Estradiol results in increased expression of ALDOA mRNA CTD PMID:15289156 ALDOC Human 17beta-estradiol decreases expression ISO Aldoc (Rattus norvegicus) 6480464 Estradiol results in decreased expression of ALDOC mRNA CTD PMID:32145629 ALDOC Human 1H-pyrazole decreases expression ISO Aldoc (Mus musculus) 6480464 pyrazole results in decreased expression of ALDOC mRNA CTD PMID:17945193 ALDOC Human 1H-pyrazole increases expression ISO Aldoc (Mus musculus) 6480464 pyrazole results in increased expression of ALDOA mRNA CTD PMID:17945193 ALDOC Human 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO Aldoc (Mus musculus) 6480464 2 more ... CTD PMID:30294300 ALDOC Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Aldoc (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ALDOA mRNA more ... CTD PMID:17942748 and PMID:19654925 ALDOC Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Aldoc (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of ALDOC mRNA CTD PMID:32109520 ALDOC Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ALDOC mRNA CTD PMID:20106945 and PMID:23152189 ALDOC Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Aldoc (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of ALDOA mRNA and Tetrachlorodibenzodioxin affects the expression of ALDOC mRNA CTD PMID:21570461 ALDOC Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Aldoc (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of ALDOA mRNA and Tetrachlorodibenzodioxin results in decreased expression of ALDOC mRNA CTD PMID:15667827 and PMID:19770486 ALDOC Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Aldoc (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of ALDOA mRNA and Tetrachlorodibenzodioxin results in increased expression of ALDOC mRNA CTD PMID:16922920 and PMID:19770486 ALDOC Human 2,4,6-tribromophenol decreases expression EXP 6480464 2 more ... CTD PMID:31675489 ALDOC Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Aldoc (Rattus norvegicus) 6480464 2 more ... CTD PMID:19954255 ALDOC Human 2,6-dimethoxyphenol multiple interactions EXP 6480464 [pyrogallol 1 more ... CTD PMID:38598786 ALDOC Human 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO Aldoc (Rattus norvegicus) 6480464 3 more ... CTD PMID:23196670 ALDOC Human 3,3',5,5'-tetrabromobisphenol A decreases expression ISO Aldoc (Mus musculus) 6480464 tetrabromobisphenol A results in decreased expression of ALDOC mRNA CTD PMID:25172293 ALDOC Human 3,4-methylenedioxymethamphetamine increases expression ISO Aldoc (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of ALDOA mRNA CTD PMID:20188158 ALDOC Human 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ALDOC mRNA CTD PMID:28628672 ALDOC Human 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ALDOC mRNA CTD PMID:28628672 ALDOC Human 4,4'-sulfonyldiphenol increases expression EXP 6480464 bisphenol S results in increased expression of ALDOC protein CTD PMID:34186270 ALDOC Human 4-hydroxynon-2-enal multiple interactions ISO Aldoc (Mus musculus) 6480464 Hydroxyurea promotes the reaction [4-hydroxy-2-nonenal binds to ALDOA protein] CTD PMID:20889679 ALDOC Human 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of ALDOC mRNA CTD PMID:16671099 ALDOC Human 4-hydroxyphenyl retinamide increases expression ISO Aldoc (Mus musculus) 6480464 Fenretinide results in increased expression of ALDOC mRNA CTD PMID:28973697 ALDOC Human 5-aza-2'-deoxycytidine increases expression EXP 6480464 Decitabine results in increased expression of ALDOC mRNA CTD PMID:17908484 ALDOC Human 6-propyl-2-thiouracil decreases expression ISO Aldoc (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of ALDOC mRNA CTD PMID:30047161 ALDOC Human aconitine increases expression ISO Aldoc (Rattus norvegicus) 6480464 Aconitine results in increased expression of ALDOC protein CTD PMID:33236894 ALDOC Human acrylamide affects expression ISO Aldoc (Rattus norvegicus) 6480464 Acrylamide affects the expression of ALDOC mRNA CTD PMID:28959563 ALDOC Human acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of ALDOC mRNA CTD PMID:32763439 ALDOC Human aflatoxin B1 decreases expression ISO Aldoc (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of ALDOC mRNA CTD PMID:19770486 ALDOC Human aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of ALDOC mRNA CTD PMID:27153756 ALDOC Human aldehydo-D-glucose multiple interactions ISO Aldoc (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of ALDOA mRNA CTD PMID:37567420 ALDOC Human aldrin decreases expression ISO Aldoc (Mus musculus) 6480464 Aldrin results in decreased expression of ALDOA mRNA CTD PMID:18579281 ALDOC Human all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of ALDOC mRNA and Tretinoin results in increased expression of ALDOC protein CTD PMID:15894607 and PMID:33167477 ALDOC Human all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of ALDOC mRNA CTD PMID:23724009 ALDOC Human alpha-phellandrene increases expression EXP 6480464 alpha phellandrene results in increased expression of ALDOC mRNA CTD PMID:25075043 ALDOC Human ammonium chloride affects expression ISO Aldoc (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of ALDOC mRNA CTD PMID:16483693 ALDOC Human Archazolid B increases expression EXP 6480464 archazolid B results in increased expression of ALDOC mRNA CTD PMID:25218289 ALDOC Human aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of ALDOC mRNA CTD PMID:33212167 ALDOC Human Aroclor 1254 decreases expression ISO Aldoc (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of ALDOA mRNA CTD PMID:23650126 ALDOC Human arsenous acid multiple interactions EXP 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ALDOC protein] CTD PMID:26598702 ALDOC Human arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of ALDOC mRNA CTD PMID:15725085 ALDOC Human atrazine increases expression EXP 6480464 Atrazine results in increased expression of ALDOC mRNA CTD PMID:22378314 ALDOC Human benzo[a]pyrene decreases expression ISO Aldoc (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of ALDOC mRNA CTD PMID:19770486 ALDOC Human benzo[a]pyrene affects expression ISO Aldoc (Mus musculus) 6480464 Benzo(a)pyrene affects the expression of ALDOA mRNA CTD PMID:22342234 ALDOC Human benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of ALDOC promoter CTD PMID:27901495 ALDOC Human benzo[a]pyrene diol epoxide I increases expression EXP 6480464 7 more ... CTD PMID:19150397 ALDOC Human bexarotene increases expression ISO Aldoc (Rattus norvegicus) 6480464 bexarotene results in increased expression of ALDOC mRNA CTD PMID:16648578 ALDOC Human bis(2-ethylhexyl) phthalate multiple interactions ISO Aldoc (Rattus norvegicus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ALDOC mRNA and [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of ALDOC protein CTD PMID:31199487 and PMID:37690569 ALDOC Human bis(2-ethylhexyl) phthalate decreases expression ISO Aldoc (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of ALDOC mRNA CTD PMID:34319233 ALDOC Human bis(2-ethylhexyl) phthalate increases expression ISO Aldoc (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of ALDOA mRNA and Diethylhexyl Phthalate results in increased expression of ALDOC mRNA CTD PMID:33754040 and PMID:35716406 ALDOC Human bisphenol A affects expression ISO Aldoc (Rattus norvegicus) 6480464 bisphenol A affects the expression of ALDOC mRNA CTD PMID:25181051 ALDOC Human bisphenol A decreases expression ISO Aldoc (Mus musculus) 6480464 bisphenol A results in decreased expression of ALDOA protein CTD PMID:35999755 ALDOC Human bisphenol A increases methylation ISO Aldoc (Mus musculus) 6480464 bisphenol A results in increased methylation of ALDOA promoter CTD PMID:27312807 ALDOC Human bisphenol A increases expression ISO Aldoc (Mus musculus) 6480464 bisphenol A results in increased expression of ALDOC mRNA CTD PMID:32156529 ALDOC Human bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ALDOC protein CTD PMID:31675489 ALDOC Human bisphenol A decreases expression ISO Aldoc (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of ALDOC mRNA CTD PMID:32145629 ALDOC Human bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ALDOC mRNA CTD PMID:30903817 ALDOC Human bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ALDOC mRNA and bisphenol A results in increased expression of ALDOC protein CTD PMID:29275510 more ... ALDOC Human bisphenol AF increases expression EXP 6480464 bisphenol AF results in increased expression of ALDOC protein CTD PMID:34186270 ALDOC Human Bisphenol B increases expression EXP 6480464 bisphenol B results in increased expression of ALDOC protein CTD PMID:34186270 ALDOC Human bisphenol F decreases expression ISO Aldoc (Mus musculus) 6480464 bisphenol F results in decreased expression of ALDOA mRNA and bisphenol F results in decreased expression of ALDOC mRNA CTD PMID:38685157 ALDOC Human bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of ALDOC protein CTD PMID:34186270 ALDOC Human bleomycin A2 multiple interactions ISO Aldoc (Mus musculus) 6480464 [Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of ALDOC protein CTD PMID:29733421 ALDOC Human butan-1-ol multiple interactions EXP 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ALDOC mRNA CTD PMID:29432896 ALDOC Human Butylbenzyl phthalate multiple interactions ISO Aldoc (Rattus norvegicus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ALDOC mRNA and [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of ALDOC protein CTD PMID:31199487 and PMID:37690569 ALDOC Human cadmium dichloride increases expression ISO Aldoc (Mus musculus) 6480464 Cadmium Chloride results in increased expression of ALDOC mRNA CTD PMID:29408670 ALDOC Human cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of ALDOC mRNA CTD PMID:38568856 ALDOC Human caffeine affects phosphorylation EXP 6480464 Caffeine affects the phosphorylation of ALDOC protein CTD PMID:35688186 ALDOC Human caffeine multiple interactions ISO Aldoc (Mus musculus) 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of ALDOA mRNA CTD PMID:28843594 ALDOC Human cannabidiol decreases expression EXP 6480464 Cannabidiol results in decreased expression of ALDOC protein CTD PMID:34122009 ALDOC Human cannabidiol increases expression ISO Aldoc (Mus musculus) 6480464 Cannabidiol results in increased expression of ALDOA mRNA CTD PMID:31052254 ALDOC Human captan increases expression ISO Aldoc (Mus musculus) 6480464 Captan results in increased expression of ALDOA mRNA and Captan results in increased expression of ALDOC mRNA CTD PMID:31558096 ALDOC Human carbon nanotube increases expression ISO Aldoc (Mus musculus) 6480464 Nanotubes and Carbon analog results in increased expression of ALDOC mRNA CTD PMID:25554681 ALDOC Human carbon nanotube affects expression ISO Aldoc (Mus musculus) 6480464 Nanotubes and Carbon affects the expression of ALDOA protein CTD PMID:21135415 ALDOC Human carbon nanotube decreases expression ISO Aldoc (Mus musculus) 6480464 Nanotubes and Carbon results in decreased expression of ALDOC mRNA CTD PMID:25620056 ALDOC Human celecoxib affects expression ISO Aldoc (Mus musculus) 6480464 Celecoxib affects the expression of ALDOC mRNA CTD PMID:20562220 ALDOC Human cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of ALDOC mRNA CTD PMID:24280081 ALDOC Human cisplatin affects expression ISO Aldoc (Mus musculus) 6480464 Cisplatin affects the expression of ALDOA mRNA CTD PMID:21151649 ALDOC Human cisplatin multiple interactions ISO Aldoc (Mus musculus) 6480464 [Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of ALDOC protein CTD PMID:29733421 ALDOC Human cisplatin multiple interactions EXP 6480464 Cisplatin promotes the reaction [jinfukang results in increased expression of ALDOC mRNA] and jinfukang promotes the reaction [Cisplatin results in increased expression of ALDOC mRNA] CTD PMID:27392435 ALDOC Human cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of ALDOC mRNA CTD PMID:27594783 ALDOC Human cisplatin decreases expression ISO Aldoc (Mus musculus) 6480464 Cisplatin results in decreased expression of ALDOC mRNA CTD PMID:24280081 ALDOC Human clozapine decreases expression ISO Aldoc (Mus musculus) 6480464 Clozapine results in decreased expression of ALDOC mRNA CTD PMID:16465460 ALDOC Human clozapine increases expression ISO Aldoc (Rattus norvegicus) 6480464 Clozapine results in increased expression of ALDOC mRNA CTD PMID:15860345 ALDOC Human cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of ALDOC mRNA CTD PMID:22202117 and PMID:24486526 ALDOC Human cobalt dichloride multiple interactions EXP 6480464 zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ALDOC mRNA] CTD PMID:22202117 ALDOC Human copper(II) chloride decreases expression ISO Aldoc (Mus musculus) 6480464 cupric chloride results in decreased expression of ALDOC protein CTD PMID:29617964 ALDOC Human copper(II) chloride increases expression ISO Aldoc (Mus musculus) 6480464 cupric chloride results in increased expression of ALDOA protein CTD PMID:29617964 ALDOC Human copper(II) chloride decreases expression EXP 6480464 cupric chloride results in decreased expression of ALDOC mRNA CTD PMID:38568856 ALDOC Human CU-O LINKAGE decreases expression EXP 6480464 cupric oxide results in decreased expression of ALDOC protein CTD PMID:25470785 ALDOC Human curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of ALDOC mRNA CTD PMID:17198877 ALDOC Human cyclosporin A decreases expression ISO Aldoc (Mus musculus) 6480464 Cyclosporine results in decreased expression of ALDOC mRNA CTD PMID:19770486 ALDOC Human cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of ALDOC mRNA CTD PMID:20106945 more ... ALDOC Human D-glucose multiple interactions ISO Aldoc (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of ALDOA mRNA CTD PMID:37567420 ALDOC Human decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of ALDOC protein CTD PMID:31675489 ALDOC Human dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ALDOC mRNA CTD PMID:28628672 ALDOC Human dexamethasone decreases expression ISO Aldoc (Mus musculus) 6480464 Dexamethasone results in decreased expression of ALDOA protein CTD PMID:33567340 ALDOC Human dextran sulfate decreases expression ISO Aldoc (Mus musculus) 6480464 Dextran Sulfate results in decreased expression of ALDOA protein and Dextran Sulfate results in decreased expression of ALDOC mRNA CTD PMID:35093514 and PMID:35999755 ALDOC Human dextran sulfate increases expression ISO Aldoc (Mus musculus) 6480464 Dextran Sulfate results in increased expression of ALDOC protein CTD PMID:35362542 ALDOC Human dextran sulfate multiple interactions ISO Aldoc (Mus musculus) 6480464 evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ALDOC protein] CTD PMID:35362542 ALDOC Human diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of ALDOC mRNA CTD PMID:15725085 ALDOC Human diarsenic trioxide multiple interactions EXP 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ALDOC protein] CTD PMID:26598702 ALDOC Human Dibutyl phosphate affects expression EXP 6480464 di-n-butylphosphoric acid affects the expression of ALDOC mRNA CTD PMID:37042841 ALDOC Human dibutyl phthalate decreases expression ISO Aldoc (Rattus norvegicus) 6480464 Dibutyl Phthalate results in decreased expression of ALDOC mRNA CTD PMID:21266533 ALDOC Human dibutyl phthalate decreases expression ISO Aldoc (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of ALDOA mRNA CTD PMID:21266533 ALDOC Human dibutyl phthalate multiple interactions ISO Aldoc (Rattus norvegicus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ALDOC mRNA and [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of ALDOC protein CTD PMID:31199487 and PMID:37690569 ALDOC Human dichlorine multiple interactions ISO Aldoc (Rattus norvegicus) 6480464 [Ozone co-treated with Chlorine] results in increased expression of ALDOC mRNA CTD PMID:18636392 ALDOC Human diclofenac increases expression ISO Aldoc (Rattus norvegicus) 6480464 Diclofenac results in increased expression of ALDOC mRNA CTD PMID:30723492 ALDOC Human diethyl phthalate multiple interactions ISO Aldoc (Rattus norvegicus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ALDOC mRNA and [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of ALDOC protein CTD PMID:31199487 and PMID:37690569 ALDOC Human diethylstilbestrol increases expression ISO Aldoc (Mus musculus) 6480464 Diethylstilbestrol results in increased expression of ALDOA mRNA CTD PMID:15289156 ALDOC Human diisobutyl phthalate multiple interactions ISO Aldoc (Rattus norvegicus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ALDOC mRNA and [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of ALDOC protein CTD PMID:31199487 and PMID:37690569 ALDOC Human diisononyl phthalate multiple interactions ISO Aldoc (Rattus norvegicus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ALDOC mRNA and [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of ALDOC protein CTD PMID:31199487 and PMID:37690569 ALDOC Human dimethylarsinic acid multiple interactions ISO Aldoc (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ALDOC mRNA CTD PMID:34876320 ALDOC Human dinophysistoxin 1 increases expression EXP 6480464 dinophysistoxin 1 results in increased expression of ALDOC mRNA CTD PMID:28939011 ALDOC Human dioxygen affects expression ISO Aldoc (Mus musculus) 6480464 Oxygen deficiency affects the expression of ALDOC mRNA CTD PMID:17193925 ALDOC Human dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of ALDOC mRNA CTD PMID:19502547 more ... ALDOC Human dioxygen increases expression ISO Aldoc (Mus musculus) 6480464 Oxygen deficiency results in increased expression of ALDOA mRNA and Oxygen deficiency results in increased expression of ALDOC mRNA CTD PMID:20880076 ALDOC Human dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate increases expression EXP 6480464 Antimony Potassium Tartrate results in increased expression of ALDOC mRNA CTD PMID:28713220 ALDOC Human dizocilpine maleate increases expression ISO Aldoc (Rattus norvegicus) 6480464 Dizocilpine Maleate results in increased expression of ALDOC protein CTD PMID:21297352 ALDOC Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 ALDOC Human doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of ALDOC mRNA CTD PMID:30031762 ALDOC Human doxorubicin multiple interactions ISO Aldoc (Mus musculus) 6480464 [Docetaxel co-treated with Doxorubicin] results in decreased expression of ALDOA protein CTD PMID:20457137 ALDOC Human doxorubicin affects expression EXP 6480464 Doxorubicin affects the expression of ALDOC mRNA CTD PMID:29803840 ALDOC Human endosulfan decreases expression ISO Aldoc (Rattus norvegicus) 6480464 Endosulfan results in decreased expression of ALDOC mRNA CTD PMID:29391264 ALDOC Human epoxiconazole decreases expression ISO Aldoc (Mus musculus) 6480464 epoxiconazole results in decreased expression of ALDOA mRNA CTD PMID:35436446 ALDOC Human ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of ALDOC mRNA CTD PMID:23378141 ALDOC Human ethanol affects splicing ISO Aldoc (Mus musculus) 6480464 Ethanol affects the splicing of ALDOA mRNA CTD PMID:30319688 ALDOC Human ethanol increases expression ISO Aldoc (Mus musculus) 6480464 Ethanol results in increased expression of ALDOA mRNA and Ethanol results in increased expression of ALDOC mRNA CTD PMID:15513904 and PMID:30319688 ALDOC Human ethanol multiple interactions ISO Aldoc (Mus musculus) 6480464 Ethanol affects the expression of and affects the splicing of ALDOC mRNA CTD PMID:30319688 ALDOC Human ethyl methanesulfonate decreases expression EXP 6480464 Ethyl Methanesulfonate results in decreased expression of ALDOC mRNA CTD PMID:23649840 ALDOC Human etoposide affects response to substance EXP 6480464 ALDOC protein affects the susceptibility to Etoposide CTD PMID:16217747 ALDOC Human etoposide multiple interactions ISO Aldoc (Mus musculus) 6480464 [Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of ALDOC protein CTD PMID:29733421 ALDOC Human Evodiamine multiple interactions ISO Aldoc (Mus musculus) 6480464 evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ALDOC protein] CTD PMID:35362542 ALDOC Human fenthion increases expression ISO Aldoc (Mus musculus) 6480464 Fenthion results in increased expression of ALDOC mRNA CTD PMID:34813904 ALDOC Human flavonoids increases expression ISO Aldoc (Rattus norvegicus) 6480464 Flavonoids results in increased expression of ALDOC mRNA CTD PMID:18035473 ALDOC Human fluoxetine increases expression EXP 6480464 Fluoxetine results in increased expression of ALDOC mRNA CTD PMID:37386098 ALDOC Human flutamide increases expression ISO Aldoc (Rattus norvegicus) 6480464 Flutamide results in increased expression of ALDOC mRNA CTD PMID:21525395 ALDOC Human flutamide increases expression ISO Aldoc (Mus musculus) 6480464 Flutamide results in increased expression of ALDOA mRNA CTD PMID:17702527 ALDOC Human folpet increases expression ISO Aldoc (Mus musculus) 6480464 folpet results in increased expression of ALDOA mRNA and folpet results in increased expression of ALDOC mRNA CTD PMID:31558096 ALDOC Human fructose multiple interactions ISO Aldoc (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of ALDOA mRNA CTD PMID:37567420 ALDOC Human fumonisin B1 increases expression ISO Aldoc (Mus musculus) 6480464 fumonisin B1 results in increased expression of ALDOA mRNA CTD PMID:16221962 ALDOC Human furan increases expression ISO Aldoc (Rattus norvegicus) 6480464 furan results in increased expression of ALDOC mRNA CTD PMID:25539665 ALDOC Human furfural multiple interactions EXP 6480464 [pyrogallol 1 more ... CTD PMID:38598786 ALDOC Human genistein multiple interactions ISO Aldoc (Rattus norvegicus) 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of ALDOC mRNA CTD PMID:21782745 ALDOC Human genistein increases expression ISO Aldoc (Mus musculus) 6480464 Genistein results in increased expression of ALDOA mRNA CTD PMID:15289156 ALDOC Human genistein decreases expression ISO Aldoc (Mus musculus) 6480464 Genistein results in decreased expression of ALDOC mRNA CTD PMID:32186404 ALDOC Human glucose multiple interactions ISO Aldoc (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of ALDOA mRNA CTD PMID:37567420 ALDOC Human haloperidol increases expression ISO Aldoc (Rattus norvegicus) 6480464 Haloperidol results in increased expression of ALDOC mRNA CTD PMID:15860345 ALDOC Human herbicide multiple interactions ISO Aldoc (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of ALDOA mRNA CTD PMID:37567420 ALDOC Human hydroxyurea multiple interactions ISO Aldoc (Mus musculus) 6480464 Hydroxyurea promotes the reaction [4-hydroxy-2-nonenal binds to ALDOA protein] CTD PMID:20889679 ALDOC Human indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ALDOC mRNA CTD PMID:28628672 ALDOC Human iron atom decreases expression EXP 6480464 Iron deficiency results in decreased expression of ALDOC mRNA CTD PMID:20368581 ALDOC Human iron(0) decreases expression EXP 6480464 Iron deficiency results in decreased expression of ALDOC mRNA CTD PMID:20368581 ALDOC Human isobutanol multiple interactions EXP 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ALDOC mRNA CTD PMID:29432896 ALDOC Human ivermectin decreases expression EXP 6480464 Ivermectin results in decreased expression of ALDOC protein CTD PMID:32959892 ALDOC Human ketamine increases expression ISO Aldoc (Rattus norvegicus) 6480464 Ketamine results in increased expression of ALDOC mRNA CTD PMID:20080153 ALDOC Human lead diacetate decreases expression ISO Aldoc (Mus musculus) 6480464 lead acetate results in decreased expression of ALDOC protein CTD PMID:20797405 ALDOC Human lead diacetate increases expression ISO Aldoc (Mus musculus) 6480464 lead acetate results in increased expression of ALDOA protein CTD PMID:20797405 ALDOC Human lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of ALDOC mRNA CTD PMID:38568856 ALDOC Human Macrosphelide A affects binding EXP 6480464 macrosphelide A binds to ALDOC protein CTD PMID:34681284 ALDOC Human maneb multiple interactions ISO Aldoc (Mus musculus) 6480464 [Paraquat co-treated with Maneb] results in decreased expression of ALDOC mRNA CTD PMID:18386188 ALDOC Human manganese(II) chloride decreases expression ISO Aldoc (Rattus norvegicus) 6480464 manganese chloride results in decreased expression of ALDOC mRNA CTD PMID:28801915 ALDOC Human methamphetamine multiple interactions ISO Aldoc (Rattus norvegicus) 6480464 2 more ... CTD PMID:18299792 ALDOC Human methamphetamine increases expression ISO Aldoc (Rattus norvegicus) 6480464 Methamphetamine results in increased expression of ALDOC protein CTD PMID:19826936 ALDOC Human methamphetamine affects localization ISO Aldoc (Rattus norvegicus) 6480464 Methamphetamine affects the localization of ALDOC mRNA CTD PMID:18299792 ALDOC Human methidathion increases expression ISO Aldoc (Mus musculus) 6480464 methidathion results in increased expression of ALDOC mRNA CTD PMID:34813904 ALDOC Human methimazole decreases expression ISO Aldoc (Rattus norvegicus) 6480464 Methimazole results in decreased expression of ALDOC mRNA CTD PMID:30047161 ALDOC Human methoxychlor multiple interactions ISO Aldoc (Rattus norvegicus) 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of ALDOC mRNA CTD PMID:21782745 ALDOC Human methyl methanesulfonate decreases expression EXP 6480464 Methyl Methanesulfonate results in decreased expression of ALDOC mRNA CTD PMID:23649840 ALDOC Human methylarsonic acid multiple interactions ISO Aldoc (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ALDOC mRNA CTD PMID:34876320 ALDOC Human methylparaben decreases expression EXP 6480464 methylparaben results in decreased expression of ALDOC mRNA CTD PMID:38568856 ALDOC Human mifepristone decreases expression EXP 6480464 Mifepristone results in decreased expression of ALDOC mRNA CTD PMID:17584828 ALDOC Human N-methyl-4-phenylpyridinium decreases expression ISO Aldoc (Rattus norvegicus) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of ALDOC mRNA CTD PMID:28801915 ALDOC Human N-methyl-4-phenylpyridinium decreases expression ISO Aldoc (Mus musculus) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of ALDOA mRNA CTD PMID:17475336 ALDOC Human nickel atom decreases expression EXP 6480464 Nickel results in decreased expression of ALDOC mRNA CTD PMID:25583101 ALDOC Human nickel dichloride multiple interactions ISO Aldoc (Mus musculus) 6480464 HIF1A affects the reaction [nickel chloride results in increased expression of ALDOA mRNA] CTD PMID:12426141 ALDOC Human nickel dichloride increases expression ISO Aldoc (Mus musculus) 6480464 nickel chloride results in increased expression of ALDOA mRNA CTD PMID:12426141 and PMID:12839937 ALDOC Human nickel sulfate increases expression EXP 6480464 nickel sulfate results in increased expression of ALDOC mRNA CTD PMID:17382205 and PMID:22714537 ALDOC Human niclosamide decreases expression EXP 6480464 Niclosamide results in decreased expression of ALDOC mRNA CTD PMID:22576131 ALDOC Human niclosamide increases expression EXP 6480464 Niclosamide results in increased expression of ALDOC mRNA CTD PMID:36318118 ALDOC Human nitrates multiple interactions ISO Aldoc (Mus musculus) 6480464 [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ALDOA mRNA CTD PMID:35964746 ALDOC Human NMN zwitterion multiple interactions ISO Aldoc (Mus musculus) 6480464 Nicotinamide Mononucleotide inhibits the reaction [Zearalenone results in decreased expression of ALDOA protein] CTD PMID:38159578 ALDOC Human obeticholic acid increases expression EXP 6480464 obeticholic acid results in increased expression of ALDOC mRNA CTD PMID:27939613 ALDOC Human oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of ALDOC mRNA CTD PMID:17762391 ALDOC Human ozone multiple interactions ISO Aldoc (Rattus norvegicus) 6480464 [Ozone co-treated with Chlorine] results in increased expression of ALDOC mRNA CTD PMID:18636392 ALDOC Human ozone multiple interactions ISO Aldoc (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ALDOC mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ALDOC mRNA CTD PMID:34911549 ALDOC Human p-chloromercuribenzoic acid decreases expression EXP 6480464 p-Chloromercuribenzoic Acid results in decreased expression of ALDOC mRNA CTD PMID:26272509 ALDOC Human p-chloromercuribenzoic acid multiple interactions EXP 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ALDOC mRNA CTD PMID:27188386 ALDOC Human paracetamol affects expression ISO Aldoc (Mus musculus) 6480464 Acetaminophen affects the expression of ALDOA mRNA and Acetaminophen affects the expression of ALDOC mRNA CTD PMID:17562736 ALDOC Human paracetamol affects expression ISO Aldoc (Rattus norvegicus) 6480464 Acetaminophen affects the expression of ALDOC mRNA CTD PMID:33387578 ALDOC Human paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of ALDOC mRNA CTD PMID:29067470 ALDOC Human paraquat multiple interactions ISO Aldoc (Mus musculus) 6480464 [Paraquat co-treated with Maneb] results in decreased expression of ALDOC mRNA CTD PMID:18386188 ALDOC Human paraquat decreases expression ISO Aldoc (Rattus norvegicus) 6480464 Paraquat results in decreased expression of ALDOC mRNA CTD PMID:32680482 ALDOC Human PCB138 decreases expression ISO Aldoc (Rattus norvegicus) 6480464 2 more ... CTD PMID:23829299 ALDOC Human pentachlorophenol increases expression ISO Aldoc (Mus musculus) 6480464 Pentachlorophenol results in increased expression of ALDOA mRNA CTD PMID:23892564 ALDOC Human perfluorobutyric acid increases expression ISO Aldoc (Mus musculus) 6480464 perfluorobutyric acid results in increased expression of ALDOA mRNA CTD PMID:34474067 ALDOC Human perfluorononanoic acid decreases expression EXP 6480464 perfluoro-n-nonanoic acid results in decreased expression of ALDOC mRNA CTD PMID:32588087 ALDOC Human perfluorooctane-1-sulfonic acid multiple interactions ISO Aldoc (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ALDOA mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of ALDOA mRNA CTD PMID:36331819 ALDOC Human perfluorooctanoic acid increases expression ISO Aldoc (Mus musculus) 6480464 perfluorooctanoic acid results in increased expression of ALDOC protein CTD PMID:37422089 ALDOC Human phenobarbital affects expression ISO Aldoc (Mus musculus) 6480464 Phenobarbital affects the expression of ALDOA mRNA CTD PMID:23091169 ALDOC Human phenylmercury acetate decreases expression EXP 6480464 Phenylmercuric Acetate results in decreased expression of ALDOC mRNA CTD PMID:26272509 ALDOC Human phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ALDOC mRNA CTD PMID:27188386 ALDOC Human phenylpropanolamine decreases expression ISO Aldoc (Mus musculus) 6480464 Phenylpropanolamine results in decreased expression of ALDOA mRNA CTD PMID:16465460 ALDOC Human picoxystrobin increases expression EXP 6480464 picoxystrobin results in increased expression of ALDOC mRNA CTD PMID:33512557 ALDOC Human pirinixic acid increases expression ISO Aldoc (Mus musculus) 6480464 pirinixic acid results in increased expression of ALDOA mRNA and pirinixic acid results in increased expression of ALDOC mRNA CTD PMID:16221962 more ... ALDOC Human potassium chromate increases expression EXP 6480464 potassium chromate(VI) results in increased expression of ALDOC mRNA CTD PMID:22714537 ALDOC Human pregnenolone 16alpha-carbonitrile decreases expression ISO Aldoc (Rattus norvegicus) 6480464 Pregnenolone Carbonitrile results in decreased expression of ALDOC mRNA CTD PMID:30047161 ALDOC Human progesterone decreases expression ISO Aldoc (Mus musculus) 6480464 Progesterone results in decreased expression of ALDOC mRNA CTD PMID:22238285 ALDOC Human propiconazole increases expression ISO Aldoc (Mus musculus) 6480464 propiconazole results in increased expression of ALDOA mRNA CTD PMID:21278054 ALDOC Human quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of ALDOC mRNA CTD PMID:21632981 ALDOC Human resveratrol increases expression EXP 6480464 resveratrol results in increased expression of ALDOC mRNA CTD PMID:15582268 ALDOC Human resveratrol decreases expression ISO Aldoc (Mus musculus) 6480464 Resveratrol results in decreased expression of ALDOA protein CTD PMID:25505154 ALDOC Human rotenone increases expression EXP 6480464 Rotenone results in increased expression of ALDOC mRNA CTD PMID:29955902 ALDOC Human rotenone increases expression ISO Aldoc (Rattus norvegicus) 6480464 Rotenone results in increased expression of ALDOC protein CTD PMID:35544339 ALDOC Human sarin affects expression ISO Aldoc (Rattus norvegicus) 6480464 Sarin affects the expression of ALDOC protein CTD PMID:28973502 ALDOC Human SB 431542 multiple interactions EXP 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:37664457 ALDOC Human silicon dioxide affects expression EXP 6480464 Silicon Dioxide analog affects the expression of ALDOC mRNA CTD PMID:25895662 ALDOC Human silver atom decreases expression ISO Aldoc (Mus musculus) 6480464 Silver results in decreased expression of ALDOC mRNA CTD PMID:27131904 ALDOC Human silver(0) decreases expression ISO Aldoc (Mus musculus) 6480464 Silver results in decreased expression of ALDOC mRNA CTD PMID:27131904 ALDOC Human SKF 38393 multiple interactions ISO Aldoc (Rattus norvegicus) 6480464 2 more ... CTD PMID:18299792 ALDOC Human sodium arsenate multiple interactions ISO Aldoc (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ALDOC mRNA CTD PMID:34876320 ALDOC Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of ALDOC mRNA CTD PMID:23648393 more ... ALDOC Human sodium arsenite multiple interactions ISO Aldoc (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ALDOC mRNA CTD PMID:34876320 ALDOC Human sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of ALDOC mRNA CTD PMID:38568856 ALDOC Human sodium arsenite decreases expression ISO Aldoc (Rattus norvegicus) 6480464 sodium arsenite results in decreased expression of ALDOC protein CTD PMID:29459688 ALDOC Human sodium chloride multiple interactions EXP 6480464 [Sodium Chloride co-treated with Furaldehyde] results in increased expression of ALDOC protein more ... CTD PMID:38598786 ALDOC Human sodium dichromate increases expression ISO Aldoc (Mus musculus) 6480464 sodium bichromate results in increased expression of ALDOA mRNA and sodium bichromate results in increased expression of ALDOC mRNA CTD PMID:31558096 ALDOC Human sodium fluoride decreases expression ISO Aldoc (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of ALDOA mRNA CTD PMID:21340527 ALDOC Human Soman decreases expression ISO Aldoc (Rattus norvegicus) 6480464 Soman results in decreased expression of ALDOC mRNA CTD PMID:19281266 ALDOC Human sotorasib multiple interactions EXP 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ALDOC mRNA CTD PMID:36139627 ALDOC Human sulindac sulfide decreases expression EXP 6480464 sulindac sulfide results in decreased expression of ALDOC mRNA CTD PMID:16184548 ALDOC Human T-2 toxin decreases expression ISO Aldoc (Rattus norvegicus) 6480464 T-2 Toxin results in decreased expression of ALDOC mRNA CTD PMID:26141394 ALDOC Human tamoxifen increases expression ISO Aldoc (Mus musculus) 6480464 Tamoxifen results in increased expression of ALDOA mRNA CTD PMID:19400957 ALDOC Human tapentadol increases expression EXP 6480464 tapentadol results in increased expression of ALDOC mRNA CTD PMID:27317026 ALDOC Human tert-butyl hydroperoxide increases expression ISO Aldoc (Mus musculus) 6480464 tert-Butylhydroperoxide results in increased expression of ALDOA mRNA CTD PMID:15003993 ALDOC Human testosterone increases expression ISO Aldoc (Mus musculus) 6480464 Testosterone deficiency results in increased expression of ALDOC mRNA CTD PMID:33848595 ALDOC Human testosterone multiple interactions ISO Aldoc (Mus musculus) 6480464 1 more ... CTD PMID:33848595 ALDOC Human tetrachloromethane decreases expression ISO Aldoc (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of ALDOC mRNA CTD PMID:31919559 ALDOC Human tetrachloromethane increases expression ISO Aldoc (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of ALDOA mRNA CTD PMID:31919559 ALDOC Human thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of ALDOC mRNA CTD PMID:22378314 ALDOC Human theophylline decreases expression EXP 6480464 Theophylline results in decreased expression of ALDOC mRNA CTD PMID:16083514 ALDOC Human thimerosal decreases expression EXP 6480464 Thimerosal results in decreased expression of ALDOC mRNA CTD PMID:27188386 ALDOC Human thioacetamide increases expression ISO Aldoc (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of ALDOC mRNA CTD PMID:23411599 ALDOC Human thiram increases expression EXP 6480464 Thiram results in increased expression of ALDOC mRNA CTD PMID:38568856 ALDOC Human titanium dioxide increases methylation ISO Aldoc (Mus musculus) 6480464 titanium dioxide results in increased methylation of ALDOA gene CTD PMID:35295148 ALDOC Human trametinib multiple interactions EXP 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ALDOC mRNA CTD PMID:36139627 ALDOC Human triclosan decreases expression EXP 6480464 Triclosan results in decreased expression of ALDOC mRNA CTD PMID:30510588 ALDOC Human trimellitic anhydride increases expression ISO Aldoc (Mus musculus) 6480464 trimellitic anhydride results in increased expression of ALDOC mRNA CTD PMID:19042947 ALDOC Human triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of ALDOC mRNA CTD PMID:37042841 ALDOC Human Triptolide decreases expression ISO Aldoc (Mus musculus) 6480464 triptolide results in decreased expression of ALDOC mRNA CTD PMID:32835833 ALDOC Human tunicamycin decreases expression EXP 6480464 Tunicamycin results in decreased expression of ALDOC mRNA CTD PMID:22378314 ALDOC Human tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of ALDOC mRNA CTD PMID:29453283 ALDOC Human valproic acid affects expression ISO Aldoc (Mus musculus) 6480464 Valproic Acid affects the expression of ALDOA mRNA and Valproic Acid affects the expression of ALDOC mRNA CTD PMID:17963808 ALDOC Human valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of ALDOC mRNA CTD PMID:25979313 ALDOC Human valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of ALDOC mRNA CTD PMID:23179753 ALDOC Human valproic acid decreases methylation EXP 6480464 Valproic Acid results in decreased methylation of ALDOC gene CTD PMID:29154799 ALDOC Human vancomycin increases expression ISO Aldoc (Mus musculus) 6480464 Vancomycin results in increased expression of ALDOC mRNA CTD PMID:18930951 ALDOC Human vincristine decreases expression EXP 6480464 Vincristine results in decreased expression of ALDOC mRNA CTD PMID:23649840 ALDOC Human vorinostat decreases expression EXP 6480464 vorinostat results in decreased expression of ALDOC mRNA CTD PMID:27188386 ALDOC Human Yessotoxin increases expression EXP 6480464 yessotoxin analog results in increased expression of ALDOC mRNA CTD PMID:30679557 ALDOC Human yohimbine multiple interactions ISO Aldoc (Mus musculus) 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of ALDOA mRNA CTD PMID:28843594 ALDOC Human zearalenone decreases expression ISO Aldoc (Mus musculus) 6480464 Zearalenone results in decreased expression of ALDOA protein and Zearalenone results in decreased expression of ALDOC protein CTD PMID:25058043 and PMID:38159578 ALDOC Human zearalenone multiple interactions ISO Aldoc (Mus musculus) 6480464 Nicotinamide Mononucleotide inhibits the reaction [Zearalenone results in decreased expression of ALDOA protein] CTD PMID:38159578 ALDOC Human zinc dichloride multiple interactions EXP 6480464 zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ALDOC mRNA] CTD PMID:22202117